EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Two Botulinum Toxin A Injections in Patients With Chronic Orofacial Myalgia: A Randomised, Double‐Blind, Controlled Multicenter Trial With Nine‐Month Follow‐Up

Christine Lennartsson iD, Ellie Saghafi iD, Behnosh Öhrnell Malekzadeh iD, Per Alstergren iD, Birgitta Johansson Cahlin iD

Journal of Oral Rehabilitation · 2025

DOI: 10.1111/joor.70032 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Oral Rehabilitation, 2025. Verfasst von Christine Lennartsson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Orofacial Pain, Mölndal, Public Dental Service, Region Västra Götaland, Sweden. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Facial Pain, Neuromuscular Agents, Myalgia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sahlgrenska Akademin, Västra Götalandsregionen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Conventional treatment for reducing pain is not always successful in patients with chronic orofacial myalgia.

Objective

The objective of this study was to investigate the pain‐reducing efficacy of two botulinum toxin A injections in patients with chronic orofacial myalgia who had already received conservative treatment.

Methods

The patients included were 18 years or older and diagnosed with myalgia according to the Diagnostic Criteria for Temporomandibular Disorders. Their pain had persisted for more than six months in spite of previous conservative treatment. The design was a randomised, double‐blind, placebo‐controlled, multicenter, parallel group study. Participants received two injections of botulinum toxin A or saline at an interval of three months. Follow‐up visits were conducted at one, three, four, six and nine months after the first injection.

Results

Seventy‐two patients were enrolled and sixty‐nine completed the study. Between baseline and all follow‐up visits, there was a significant decrease in VAS pain intensity for both groups, but the difference between groups was not significant.

Conclusion

The use of botulinum toxin A in managing chronic orofacial myalgia did not offer any additional pain relief compared with saline at any of the follow‐up occasions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AFacial PainNeuromuscular AgentsMyalgiaChronic PainHumansDouble-Blind MethodFemaleMaleMiddle AgedTreatment OutcomeFollow-Up StudiesPain MeasurementAdultInjections, IntramuscularAgedTemporomandibular Joint Disorders

Stichwörter der Autor:innen

botulinum toxinchronic painmyalgiaorofacial painrandomised controlled trialtemporomandibular disorders

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Clinic of Orofacial Pain, Mölndal, Public Dental Service, Region Västra Götaland, Sweden.
  • Department of Orofacial Pain, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Clinic of Orofacial Pain, Gothenburg, Public Dental Service, Region Västra Götaland, Sweden.
  • Department of Oral and Maxillofacial Surgery, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Clinic of Oral and Maxillofacial Surgery, Borås, Public Dental Service, Region Västra Götaland, Sweden.
  • Department of Orofacial Pain and Jaw Function, Faculty of Odontology, Malmö University, Malmö, Sweden.

ORCID-Profile: Christine Lennartsson, Ellie Saghafi, Behnosh Öhrnell Malekzadeh, Per Alstergren, Birgitta Johansson Cahlin

Förderung

  • Sahlgrenska Akademin
  • Västra Götalandsregionen

Zitieren

APA

Lennartsson, C., Saghafi, E., Malekzadeh, B. Ö., Alstergren, P., & Cahlin, B. J. (2025). Two Botulinum Toxin A Injections in Patients With Chronic Orofacial Myalgia: A Randomised, Double‐Blind, Controlled Multicenter Trial With Nine‐Month Follow‐Up. Journal of Oral Rehabilitation. https://doi.org/10.1111/joor.70032

Vancouver

Lennartsson C, Saghafi E, Malekzadeh BÖ, Alstergren P, Cahlin BJ. Two Botulinum Toxin A Injections in Patients With Chronic Orofacial Myalgia: A Randomised, Double‐Blind, Controlled Multicenter Trial With Nine‐Month Follow‐Up. Journal of Oral Rehabilitation. 2025. doi:10.1111/joor.70032

BibTeX
@article{Lennartsson2025,
  author = {Lennartsson, Christine and Saghafi, Ellie and Malekzadeh, Behnosh Öhrnell and Alstergren, Per and Cahlin, Birgitta Johansson},
  title = {Two Botulinum Toxin A Injections in Patients With Chronic Orofacial Myalgia: A Randomised, Double‐Blind, Controlled Multicenter Trial With Nine‐Month Follow‐Up},
  journal = {Journal of Oral Rehabilitation},
  year = {2025},
  doi = {10.1111/joor.70032}
}
Kostenlos starten →